SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Pyth Network is a decentralised oracle network designed to provide real-time financial market data to decentralised applications (dApps) across multiple blockchains. It allows developer to secure smart contracts with reliable, low-latency market data from institutional sources, and build apps with high-fidelity oracle feeds designed for mission-critical systems.

Pyth Network

Pyth Network is trending due to its selection by the U.S. Department of Commerce to distribute economic data on-chain, a move seen as a major step for decentralized infrastructure. The community is actively discussing potential price targets and the broader implications of government adoption of blockchain technology. Some users also believe that this could be the start of a long term hold.

Krypto Cock is a meme-powered crypto project with real onchain utility. Born from the lessons of past market cycles, $COCK blends humor, culture, and technology to create a unique community-driven ecosystem.  The project is focused on: • Building lightweight mini-apps for Farcaster and other onchain platforms • Developing an engaged, growing community • Delivering consistent, high-quality content • Offering practical onchain tools and experiences • Led by a team with years of crypto and product experience  $COCK aims to make the crypto experience more fun, accessible, and connected, without sacrificing purpose or quality.

CockCardano

$COCK.X is trending due to the launch of Cocky Wings LLC, a real-world asset bringing utility to the meme coin; the community is excited about the potential for buybacks and real revenue. Cocky Wings will launch at the South Carolina Gamecocks homegame, aiming to onboard college football fans.

Dog (Bitcoin) is a fully decentralized memecoin on the Bitcoin blockchain, backed by a community dedicated to onboarding millions of people to Bitcoin.  Dog is secured by the Bitcoin blockchain and exists on Bitcoin L1, marking a significant innovation compared to Bitcoin with just BTC. Dog is a Bitcoin Runes token with a minimal on-chain footprint, native to Bitcoin, and stored in UTXOs, just like Bitcoin.   What is the project about?  Dog does not do any paid promotion and is fully decentralized just like Bitcoin. Every influencer who chooses to post about Dog either received the airdrop or bought on secondary. Dog leverages the CC0 license to ensure that Dog is not owned by any single entity but rather by everyone. This had lead to the "DOG Army" independently creating art, apps, lotteries, plushies, websites, podcast, magazines, X account, IRL meetups, clothing lines, PFP collections, Telegram groups, and TikTok/Instagram about Dog.  What makes your project unique?  Dog was airdropped in the fairest memecoin launch ever. In early 2024, the Bitcoin Ordinals ecosystem came together in a full volunteer initiative that rewarded early adopters of the Ordinals Protocol. There was no team allocation, and 100% of the supply was airdropped for free. The airdrop algorithm favored neither whales nor influencers; it was determined by the community and made open-source for maximum transparency.

Dog (Bitcoin)

$DOG.X, a memecoin on the Bitcoin network, is trending as the community rallies around its fair distribution and potential to outperform other meme coins. Some believe it could become the leading meme on Bitcoin, citing its strong community and organic growth. The potential for listings on major exchanges and the backing of a publicly listed company, $CBLO, are also fueling interest.

WorldFinancial

WorldFinancial ($WLFI.X) is trending as the community discusses its potential, governance, and links to prominent figures. Community members are weighing in on potential buybacks, token burns, and the possibility of mass adoption through real-world asset tokenization. Some traders are noting recent price volatility and debating whether it presents a buying opportunity or a sign of a pump and dump scheme.

ProShares Trust - ProShares Short Dow30 -1x Shares

ProShares Short Dow30

$DOG is trending as the community discusses its potential as the 'DOGE of Bitcoin' and its fair, presale-free distribution. Bullish sentiment surrounds CBLO's increasing treasury holdings of DOG coins, with some anticipating ETF possibilities and tier 1 exchange listings. Conversation highlights $DOG's strong community and its activities within the Bitcoin ecosystem, particularly regarding Runestones and Ordinals.

Cardano is a proof-of-stake blockchain platform designed to support decentralized applications (dApps), featuring a multi-asset ledger and smart contract functionality. Unlike many other blockchains, Cardano is built from the ground up based on original academic research, with proposed solutions undergoing peer review and presentation at international conferences before development. The platform emphasizes a research-driven and formal methods approach to design and implementation.

Cardano

Cardano is trending as the community discusses the launch of Cocky Wings, a real-world asset project powered by the $COCK token on the ADA chain. This initiative aims to integrate Cardano with a tangible business, attracting new users and showcasing real-world applications. Community members are also closely monitoring technical analysis, speculating on potential price movements and future growth.

StickyFam

StickyFam ($FAM.X) is trending as the community rallies around its potential, highlighting its growing follower base and recent listing on BingX. Comparisons to coins within the $DOGE.X and $SOL.X ecosystem are circulating, with many believing that $FAM.X is still early and poised for significant growth due to upcoming catalysts like CEX listings.

Wrapped Centrifuge

Wrapped Centrifuge is gaining attention as community members actively discuss its potential breakout and encourage others to take a look. Some users point to news and increasing volume as potential catalysts, while others highlight its low supply. There's also discussion around the difference between $CFG.X and $WCFG.X.

Alcoa Corp. engages in the bauxite mining, alumina refining, and aluminum smelting and casting. It operates through the Alumina and Aluminum segments. The Alumina segment consists of a refining system, including the mining of bauxite, which is then refined into alumina, a compound of aluminum and oxygen that is the raw material used by smelters to produce aluminum metal. The Aluminum segment is composed of smelting and casthouse system. The company was founded by Charles Martin Hall on July 9, 1886 and is headquartered in Pittsburgh, PA.

Alcoa Corp

Alcoa ($AA) is trending as the community discusses its strong earnings report and potential benefits from tariffs, though some caution about potential headwinds. Bullish sentiment is fueled by analyst upgrades and a positive long-term outlook, while others are wary of short-term volatility. Community members are actively trading options, anticipating price movements based on the latest news.

Gyrodyne LLC engages in the management of a portfolio of medical office and industrial properties. Its properties include Flowerfield, Port Jefferson Professional Park, Courtland Medical Center, and Grove. The company was founded by Peter James Papadakos in 1946 and is headquartered in St. James, NY.

Gyrodyne LLC

GYRO is trending due to a recently announced land sale, which the company anticipates will significantly boost its net asset value per share. The stock's low float is fueling speculation of a potential parabolic run, with community members comparing it to other recent low-float runners. Discussions also focus on key breakout levels and potential price targets amid the increased attention.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

MYGN's GeneSight Test Proven Superior to TAU: Stock to Gain?

Myriad Genetics' GeneSight test outperforms treatment-as-usual in major depression, raising hopes for broader adoption and renewed stock momentum.

Compared to Estimates, Myriad (MYGN) Q2 Earnings: A Look at Key Metrics

The headline numbers for Myriad (MYGN) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Myriad Genetics (MYGN) Q2 Earnings and Revenues Surpass Estimates

Myriad (MYGN) delivered earnings and revenue surprises of +600.00% and +5.55%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Tempus AI Boosts R&D Efforts Through Wide-Ranging Product Launches

TEM expands its precision medicine arsenal with AI-powered tools, liquid biopsy tech and genome sequencing.

Tempus AI Eyes Positive Adjusted EBITDA in 2025: Is It Taking Shape?

Myriad (MYGN) Up 23.9% Since Last Earnings Report: Can It Continue?

Shares of Myriad Genetics&nbsp;slumped Wednesday as analysts issued a flurry of downgrades and price target cuts following a weak first quarter and lowered guidance.&nbsp;Wells Fargo downgraded the stock to ‘Equal Weight’ from ‘Overweight’, slashing its price target to $6 from $22.&nbsp;The stock plunged 41.3% to close at $4.27 on Wednesday.Analyst Brandon Couillard cited a “noisy” quarterly performance, reduced visibility, and low conviction in the company’s growth and margin outlook through 2026.Couillard warned that Myriad's revised 2025 guidance still implies a second-half inflection in volume growth, making the stock a “show-me story” that needs stronger execution and strategic clarity before investor sentiment can recover.Myriad reported Q1 revenue of $196 million, down 3% year-over-year. Adjusted for $16 million in headwinds, revenue grew 5%.&nbsp;The company posted a GAAP net loss of $0.1 million, supported by a $29 million tax benefit,&nbsp;while adjusted loss per share came in at $0.03.&nbsp;The company now expects full-year adjusted EPS in the range of a loss of $0.02 to a profit of $0.02, and trimmed its revenue outlook to $807–$823 million.Analyst sentiment turned broadly cautious.UBS lowered its price target to $7 from $16 while maintaining a ‘Neutral’ rating.Raymond James trimmed its target to $10 from $19 but kept an ‘Outperform’ rating, citing “somewhat soft” Q1 results and a 4% guidance cut under new CEO Sam Raha.&nbsp;Craig-Hallum cut its target to $18 from $29 but reiterated a ‘Buy,’ arguing that while recovery appears more difficult than expected, the stock’s valuation looks disconnected from longer-term potential.&nbsp;Wolfe Research also downgraded the stock to ‘Peer Perform.’Key weaknesses centered on the 20% drop in pharmacogenomics revenue, mainly tied to UnitedHealthcare's cut to GeneSight coverage.&nbsp;Oncology remained a bright spot, with hereditary cancer testing volumes in affected populations rising 11% year-over-year.Despite the cautious analyst tone, Stocktwits sentiment was marked as ‘extremely bullish’ amid ‘extremely high’ message volume.&nbsp;One user noted they were considering buying shares, calling the stock “cheap.”&nbsp;<stembedurl>https://stocktwits.com/Harunkaraca/message/613823074</stembedurl>Another reflected on owning Myriad in the past and questioned the growth outlook after GeneSight brought in just $31 million during the quarter. However, they still described the share price as attractive and cited a decent balance sheet, indicating they had bought after hours.<stembedurl>https://stocktwits.com/pilobious/message/613722246</stembedurl>Shares of Myriad have fallen over 68% so far this year.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Representative image of stock price falling.

Myriad Genetics Shares Tank 41% On Analyst Downgrades, Weaker Guidance: Yet Retail Investors Remain Bullish

Analysts, including those from Wells Fargo, UBS, Raymond James, and Craig-Hallum, slashed their price targets and expressed concerns over the company's growth and execution challenges. 

Equity

Myriad Genetics (MYGN) Reports Q1 Loss, Misses Revenue Estimates

MYGN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Myriad Genetics, Inc. and Encourages Investors to Contact the Firm

Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Myriad Genetics, Inc. (Myriad or the Company) (NASDAQ: MYGN). Investors who...

MYGN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Myriad Genetics, Inc. and Encourages Investors to Contact the Firm MYGN INVESTOR ALERT: Bronstein, Gewirtz...

Myriad Genetics, Inc. engages in the discovery, development, and marketing of transformative molecular diagnostic tests. The company was founded by Walter A. Gilbert, Mark H. Skolnick, and Peter D. Meldrum in May 1991 and is headquartered in Salt Lake City, UT.

MYGN
Myriad Genetics, Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest MYGN News

MYGN Myriad Genetics, Inc.